Redx Pharma (REDX)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

14.25p
   
  • Change Today:
      0.65p
  • 52 Week High: 33.13
  • 52 Week Low: 4.00
  • Currency: UK Pounds
  • Shares Issued: 126.48m
  • Volume: 78,152
  • Market Cap: 18.02m
  • RiskGrade: 1,124
  • Beta: 0.04

Redx Pharma Overview

Redx Pharma is in the pharma and biotech sector and is currently trading at 14.25p per share. In the last year Redx Pharma's share price has ranged from 4.00p to 33.13p.

1 Day Chart (18-05-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.5% n/a
ROCE 8.9%  
Latest F'cast
P/E 10.2 n/a
PEG n/a n/a
Pr/Revenue 0.6 n/a
Pr/Book 1.3  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Redx Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-14 n/a (4.26) (7.60)p n/a n/a n/a n/a 0.0%
30-Sep-15 n/a (8.82) (14.10)p n/a n/a n/a n/a 0.0%
30-Sep-16 n/a (15.41) (19.80)p n/a n/a n/a n/a 0.0%
30-Sep-17 30.47 1.65 1.40p 23.1 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Redx Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-18 n/a (8.65) (6.50)p n/a n/a n/a n/a 0.0%
30-Sep-19 n/a (13.33) (8.80)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Redx Pharma Company Announcements

Share Purchase by Chairman 25-Apr-2018 10:57 RNS
Second Price Monitoring Extn 25-Apr-2018 09:05 RNS
Price Monitoring Extension 25-Apr-2018 09:00 RNS

Latest Redx Pharma Director Deals

Traded Action Notifier PriceAmountValue
25-Apr-18 Buy Iain Ross 11.00p 150,000 16,500.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 14.25p
Change Today 0.65p
% Change 4.78 %
52 Week High 33.13
52 Week Low 4.00
Volume 78,152
Shares Issued 126.48m
Market Cap 18.02m
Beta 0.04
RiskGrade 1,124

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.51% above the market average36.51% above the market average36.51% above the market average36.51% above the market average36.51% above the market average
65.08% above the sector average65.08% above the sector average65.08% above the sector average65.08% above the sector average65.08% above the sector average
Price Trend
89.3% below the market average89.3% below the market average89.3% below the market average89.3% below the market average89.3% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average
Income Not Available
Growth Not Available

Redx Pharma Dividends

No dividends found

Trades for 18-May-2018

Time Volume / Share Price
15:55 1,526 @ 13.70p
14:51 3,707 @ 13.65p
13:38 26,237 @ 14.15p
11:50 2,625 @ 14.15p
11:37 8,500 @ 14.15p

Redx Pharma Key Personnel

CFO Dominic Jackson

Top of Page